152 related articles for article (PubMed ID: 35813967)
41. Epidemiology and cost of cervical cancer care and prevention in Apulia (Italy), 2007/2016.
Bianchi FP; Gallone MS; Fortunato F; Boccalini S; Martinelli D; Prato R; Tafuri S
Ann Ig; 2018; 30(6):490-501. PubMed ID: 30614498
[TBL] [Abstract][Full Text] [Related]
42. Knowledge and Attitudes of Women towards Human Papilloma Virus and HPV Vaccine in Thulamela Municipality of Vhembe District in Limpopo Province, South Africa.
Ramathuba DU; Ngambi D
Afr J Reprod Health; 2018 Sep; 22(3):111-119. PubMed ID: 30381938
[TBL] [Abstract][Full Text] [Related]
43. Second primary anal and oropharyngeal cancers in cervical cancer survivors.
Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S
Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108
[TBL] [Abstract][Full Text] [Related]
44. Trends in cervical cancer incidence and mortality in Oklahoma and the United States, 1999-2013.
Gopalani SV; Janitz AE; Campbell JE
Cancer Epidemiol; 2018 Oct; 56():140-145. PubMed ID: 30176544
[TBL] [Abstract][Full Text] [Related]
45. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.
Bosch FX; Manos MM; Muñoz N; Sherman M; Jansen AM; Peto J; Schiffman MH; Moreno V; Kurman R; Shah KV
J Natl Cancer Inst; 1995 Jun; 87(11):796-802. PubMed ID: 7791229
[TBL] [Abstract][Full Text] [Related]
46. Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study.
Ryzhov A; Corbex M; Piñeros M; Barchuk A; Andreasyan D; Djanklich S; Ghervas V; Gretsova O; Kaidarova D; Kazanjan K; Mardanli F; Michailovich Y; Ten E; Yaumenenka A; Bray F; Znaor A
Lancet Oncol; 2021 Mar; 22(3):361-369. PubMed ID: 33556324
[TBL] [Abstract][Full Text] [Related]
47. Association of oral contraceptive use and human papillomaviruses in invasive cervical cancers.
Hildesheim A; Reeves WC; Brinton LA; Lavery C; Brenes M; De La Guardia ME; Godoy J; Rawls WE
Int J Cancer; 1990 May; 45(5):860-4. PubMed ID: 2159437
[TBL] [Abstract][Full Text] [Related]
48. Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program.
Frost JJ; Sonfield A; Zolna MR; Finer LB
Milbank Q; 2014 Dec; 92(4):696-749. PubMed ID: 25314928
[TBL] [Abstract][Full Text] [Related]
49. U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality.
Horner MJ; Altekruse SF; Zou Z; Wideroff L; Katki HA; Stinchcomb DG
Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):591-9. PubMed ID: 21266522
[TBL] [Abstract][Full Text] [Related]
50. Preventable mortality in the Russian Federation: a retrospective, regional level study.
Nikoloski Z; Shkolnikov VM; Mossialos E
Lancet Reg Health Eur; 2023 Jun; 29():100631. PubMed ID: 37180281
[TBL] [Abstract][Full Text] [Related]
51. Morbidity and mortality of the Russian population from acute respiratory viral infections, pneumonia and vaccination.
Bilichenko TN; Chuchalin AG
Ter Arkh; 2018 Feb; 90(1):22-26. PubMed ID: 30701753
[TBL] [Abstract][Full Text] [Related]
52. Eliminating Cervical Cancer in Mali and Senegal, Two Sub-Saharan Countries: Insights and Optimizing Solutions.
Haque A; Kouriba B; Aïssatou N; Pant A
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32295116
[TBL] [Abstract][Full Text] [Related]
53. Incidence and mortality of cervical cancer in China, 2013.
Song B; Ding C; Chen W; Sun H; Zhang M; Chen W
Chin J Cancer Res; 2017 Dec; 29(6):471-476. PubMed ID: 29353969
[TBL] [Abstract][Full Text] [Related]
54. Vital and health statistics: Russian Federation and United States, selected years 1985-2000 with an overview of Russian mortality in the 1990s.
Notzon FC; Komarov YM; Ermakov SP; Savinykh AI; Hanson MB; Albertorio J
Vital Health Stat 5; 2003 Jun; (11):1-55, 1-58. PubMed ID: 14509124
[TBL] [Abstract][Full Text] [Related]
55. Oncogenic human papilloma virus and cervical pre-cancerous lesions in brothel-based sex workers in India.
Sarkar K; Bhattacharya S; Bhattacharyya S; Chatterjee S; Mallick AH; Chakraborti S; Chatterjee D; Bal B
J Infect Public Health; 2008; 1(2):121-8. PubMed ID: 20701853
[TBL] [Abstract][Full Text] [Related]
56. Cervical cancer risk perceptions, sexual risk behaviors and sexually transmitted infections among Bivalent Human Papillomavirus vaccinated and non-vaccinated young women in Uganda - 5 year follow up study.
Kumakech E; Andersson S; Wabinga H; Musubika C; Kirimunda S; Berggren V
BMC Womens Health; 2017 Jun; 17(1):40. PubMed ID: 28576143
[TBL] [Abstract][Full Text] [Related]
57. Risk factors for cervical cancer in Colombia and Spain.
Bosch FX; Muñoz N; de Sanjosé S; Izarzugaza I; Gili M; Viladiu P; Tormo MJ; Moreo P; Ascunce N; Gonzalez LC
Int J Cancer; 1992 Nov; 52(5):750-8. PubMed ID: 1330934
[TBL] [Abstract][Full Text] [Related]
58. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
[TBL] [Abstract][Full Text] [Related]
59. Awareness of human papilloma virus and cervical cancer prevention among Greek female healthcare workers.
Farazi PA; Hadji P; Roupa Z
Eur J Cancer Prev; 2017 Jul; 26(4):330-335. PubMed ID: 27254169
[TBL] [Abstract][Full Text] [Related]
60. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
